Erschienen in:
13.10.2018 | Original Article
Prognostic impact of multifocal and multicentric breast cancer versus unifocal breast cancer
verfasst von:
Atsushi Fushimi, Atsushi Yoshida, Hiroshi Yagata, Osamu Takahashi, Naoki Hayashi, Koyu Suzuki, Hiroko Tsunoda, Seigo Nakamura, Hideko Yamauchi
Erschienen in:
Surgery Today
|
Ausgabe 3/2019
Einloggen, um Zugang zu erhalten
Abstract
Purposes
The clinical behavior of multifocal and multicentric breast cancers (MMBCs) is not well characterized. We conducted this study to ascertain whether patients with MMBCs have a worse prognosis than patients with unifocal breast cancers (UBC).
Methods
The subjects of this retrospective study were 734 consecutive patients who underwent definitive surgery for invasive breast carcinoma at our hospital between January 2004 and December 2006. MMBC was defined as ≥ 2 separate invasive unilateral breast tumors and pathological T stage was redefined based on the sum of the maximum diameter of each tumor. We evaluated disease-free survival (DFS) using the Kaplan–Meier method and Cox proportional hazards models.
Results
Of the 734 patients, 136 (18.5%) had MMBC. The pathological T stage of 36 of the patients with MMBC was upstaged by adopting the sum of each focus. MMBC did not have any survival impact, but MMBC upstaged by the modified pathological T stage was associated with worse DFS than non-upstaging MMBC (P = 0.004). Multivariate analysis revealed that upstaging MMBC was an independent factor for poor prognosis and worse DFS (HR 2.757, P = 0.043).
Conclusions
MMBC itself may not be predictive of a worse prognosis; however, the sum of the invasive diameters of MMBC might be an important prognostic factor. Further studies are needed to confirm the prognosis associated with MMBC, taking into consideration the biological characteristics of each invasive focus.